Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
International Journal of Nanomedicine
|
December 12, 2019
Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery
Alastair F Breen, David Scurr, Maria Letizia Cassioli, et al.
Journal of Medicinal Chemistry
|
January 6, 2006
Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines
Catriona G Mortimer, Geoffrey Wells, Jean-Philippe Crochard, et al.
Pharmaceutics
|
June 26, 2026
Targeting SARS-CoV-2 Structural and Accessory Proteins: Emerging Opportunities for Small-Molecule Coronavirus Antivirals
Exequiel O J Porta, Dana F AlKharboush, Lauren Jackson, et al.
Journal of Medicinal Chemistry
|
February 7, 2003
4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines
Geoffrey Wells, Jane M Berry, Tracey D Bradshaw, et al.
Pharmaceutics
|
June 26, 2026
Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals
Exequiel O J Porta, Dana F AlKharboush, Lauren Jackson, et al.
Chemistryopen
|
October 26, 2022
Synthesis and Anti-Inflammatory Activity of 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-Derived NRF2 Activators
Kit-Kay Mak, Zhang Shiming, Ola Epemolu, et al.
Chemmedchem
|
May 14, 2014
3-(2-oxoethylidene)indolin-2-one derivatives activate Nrf2 and inhibit NF-κB: potential candidates for chemoprevention
Amrita A Nagle, Shridhivya A Reddy, Helene Bertrand, et al.
Radiation Oncology (London, England)
|
July 25, 2022
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Andrew W See, Patrick Bowden, Geoffrey Wells, et al.
Oncotarget
|
June 1, 2016
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
Kamila K Kaminska, Helene C Bertrand, Hisashi Tajima, et al.
Biochimie
|
August 3, 2018
The mycosporine-like amino acids porphyra-334 and shinorine are antioxidants and direct antagonists of Keap1-Nrf2 binding
Ranko Gacesa, Karl P Lawrence, Nikolaos D Georgakopoulos, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
International Journal of Nanomedicine
|
December 12, 2019
Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery
Alastair F Breen, David Scurr, Maria Letizia Cassioli, et al.
Journal of Medicinal Chemistry
|
January 6, 2006
Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines
Catriona G Mortimer, Geoffrey Wells, Jean-Philippe Crochard, et al.
Pharmaceutics
|
June 26, 2026
Targeting SARS-CoV-2 Structural and Accessory Proteins: Emerging Opportunities for Small-Molecule Coronavirus Antivirals
Exequiel O J Porta, Dana F AlKharboush, Lauren Jackson, et al.
Journal of Medicinal Chemistry
|
February 7, 2003
4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines
Geoffrey Wells, Jane M Berry, Tracey D Bradshaw, et al.
Pharmaceutics
|
June 26, 2026
Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals
Exequiel O J Porta, Dana F AlKharboush, Lauren Jackson, et al.
Chemistryopen
|
October 26, 2022
Synthesis and Anti-Inflammatory Activity of 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-Derived NRF2 Activators
Kit-Kay Mak, Zhang Shiming, Ola Epemolu, et al.
Chemmedchem
|
May 14, 2014
3-(2-oxoethylidene)indolin-2-one derivatives activate Nrf2 and inhibit NF-κB: potential candidates for chemoprevention
Amrita A Nagle, Shridhivya A Reddy, Helene Bertrand, et al.
Radiation Oncology (London, England)
|
July 25, 2022
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Andrew W See, Patrick Bowden, Geoffrey Wells, et al.
Oncotarget
|
June 1, 2016
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
Kamila K Kaminska, Helene C Bertrand, Hisashi Tajima, et al.
Biochimie
|
August 3, 2018
The mycosporine-like amino acids porphyra-334 and shinorine are antioxidants and direct antagonists of Keap1-Nrf2 binding
Ranko Gacesa, Karl P Lawrence, Nikolaos D Georgakopoulos, et al.
Page
of 5